Market Overview 2025-2033
The Mexico interventional cardiology devices market size reached USD 367.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 652.1 Million by 2033, exhibiting a growth rate (CAGR) of 6.58% during 2025-2033. The market is growing due to rising cardiovascular disease prevalence, increasing adoption of minimally invasive procedures, and expanding healthcare infrastructure. Growth is driven by advanced stents and accessory devices, regulatory support, and technological innovation, making the industry more dynamic, efficient, and competitive.
Key Market Highlights:
✔️ Strong market growth driven by rising prevalence of cardiovascular diseases and aging population
✔️ Increasing adoption of minimally invasive procedures and advanced stent technologies
✔️ Expanding healthcare infrastructure and government initiatives improving access to cardiac care solutions
Request for a sample copy of the report: https://www.imarcgroup.com/mexico-interventional-cardiology-devices-market/requestsample
Mexico Interventional Cardiology Devices Market Trends and Drivers:
The Mexico Interventional Cardiology Devices Market is witnessing accelerated growth, primarily driven by the increasing burden of cardiovascular disease (CVD), which remains a leading cause of mortality. According to INEGI (2025), CVD accounts for 25% of annual deaths in the country, with urbanization, poor dietary habits, and sedentary lifestyles contributing to rising cases of hypertension and diabetes. This has led to growing demand for minimally invasive cardiac procedures such as angioplasty and stent placements. Public institutions like IMSS and ISSSTE have expanded catheterization labs, while private hospitals in major urban centers like Monterrey and Guadalajara are reporting an 18% year-on-year increase in Percutaneous Coronary Interventions (PCI). The introduction of Universal Healthcare Coverage in 2024 further boosted access to interventional devices, particularly drug-eluting stents and guidewires.
Despite this momentum, affordability remains a key challenge in expanding the Mexico Interventional Cardiology Devices Market Size, especially with 80% of advanced devices like bioresorbable scaffolds still imported and subject to high tariffs. Domestic players, such as SteriHealth, are attempting to bridge this gap through joint ventures with multinational firms like Medtronic to manufacture bare-metal stents locally by the end of 2024. However, technological and R&D limitations continue to hinder the production of more complex devices.
Technological innovation is transforming the landscape. AI-powered imaging platforms and robotic-assisted systems are improving procedural accuracy and reducing complications. Following COFEPRIS’s 2023 regulatory reforms, devices like intravascular ultrasound (IVUS) and optical coherence tomography (OCT) have seen a 30% adoption increase in private centers. TecSalud’s “Smart Cath Lab,” launched in 2024, integrates Siemens’ AI-driven hemodynamic monitoring tools to reduce risks such as contrast-induced nephropathy.
Meanwhile, strategic foreign investments are reshaping the Mexico Interventional Cardiology Devices Market Share. The 2024 USMCA tariff exemptions have prompted U.S. firms like Edwards Lifesciences to scale up manufacturing in Querétaro, while Chinese manufacturers such as MicroPort have gained traction in the public sector by offering competitively priced coronary balloons. Local startups like CardioMex are also gaining investor attention, securing $20 million in funding for AI-based fractional flow reserve (FFR) technologies.
However, key barriers remain, including a shortage of trained specialists—only 350 interventional cardiologists currently serve a population of 130 million. Efforts like Grupo Ángeles’ partnership with Johns Hopkins aim to expand clinical expertise. Looking forward, the market is expected to pivot toward value-based care, favoring micro-invasive devices and localized product development, while broader access and reimbursement alignment will be essential for long-term growth.
Mexico Interventional Cardiology Devices Market Segmentation:
The market report segments the market based on product type, distribution channel, and region:
Study Period:
Base Year: 2024
Historical Year: 2019-2024
Forecast Year: 2025-2033
Breakup by Product:
- Stents
- Drug Eluting Stents
- Bare Metal Stents
- Bio-Absorbable Stents
- Interventional Catheters
- IVUS Catheters
- Guiding Catheters
- Angiography Catheters
- PTCA Guidewires
- Balloon Inflation Device
- PTCA Balloons
- Cutting Balloons
- Scoring Balloons
- Drug Eluting Balloons
- Normal Balloons
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
Breakup by Region:
- Northern Mexico
- Central Mexico
- Southern Mexico
- Others
Competitive Landscape:
The market research report offers an in-depth analysis of the competitive landscape, covering market structure, key player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant. Additionally, detailed profiles of all major companies are included.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
